Stock Events

Stock Events

HAVN Life Sciences 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-7,970.24%Profit Margin
Unprofitable
2019
2020
2021
202,451.43Revenue
-16.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5NP.MU. It's not an investment recommendation.
Compass Pathways
4
CMPS
Tesla
3
TSLA
Zim Integrated Shipping Services
3
ZIM
Revive Therapeutics
3
RVVTF

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with HAVN's research and development in psychedelic compounds.
AtaiBeckley
ATAI
Mkt Cap1.9B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health disorders, overlapping with HAVN's mission.
GH Research
GHRS
Mkt Cap1.82B
GH Research PLC is involved in the development of therapeutic solutions using psychedelic substances, which aligns with HAVN's focus areas.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness Inc. is engaged in psychedelic therapy research and development, offering services that compete with HAVN's offerings.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics focuses on the research and development of psychedelics for medical use, including treatments for mental health disorders.
TripAdvisor
TRIP
Mkt Cap1.63B
Red Light Holland Corp. is involved in the production, growth, and sale of a premium brand of magic truffles, competing in the psychedelics market.
Noveris Health Sciences
MYCOF
Mkt Cap64.4M
Mydecine Innovations Group Inc. specializes in the development and production of adaptive pathway medicines, including psychedelics, which puts them in competition with HAVN Life Sciences.

About

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Show more...
CEO
Mr. Tim Moore
Employees
6
Country
Canada
ISIN
CA4196211078

Listings

MU
DE
5NP.MU
STU
DE
5NP0.STU
MU
DE
5NP0.MU
CN
CA
HAVN.CN

0 Comments

Share your thoughts

FAQ

What is HAVN Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange HAVN Life Sciences stocks are traded under the ticker 5NP.MU.
What is HAVN Life Sciences revenue for the last year?▼
HAVN Life Sciences revenue for the last year amounts to 202,451.43 EUR.
What is HAVN Life Sciences net income for the last year?▼
5NP.MU net income for the last year is -16.14M EUR.
How many employees does HAVN Life Sciences have?▼
As of July 26, 2026, the company has 6 employees.
In which sector is HAVN Life Sciences located?▼
HAVN Life Sciences operates in the Health & Wellness sector.
When did HAVN Life Sciences complete a stock split?▼
The last stock split for HAVN Life Sciences was on August 03, 2022 with a ratio of 1:30.
Where is HAVN Life Sciences headquartered?▼
HAVN Life Sciences is headquartered in Port Moody, Canada.